Table 4.

Genotype and allele frequencies of the HPSE gene SNPs in CMV seropositive patients with hematological malignancies.

SNP	Genotype and Alleles	ALL		MDS		MM		NHL		p-Value to CMV-Seropositive Controls	p-Value to CMV-Seronegative Controls
		№	Incidence (%)	№	Incidence (%)	№	Incidence (%)	№	Incidence (%)
rs4693608	AA	11	22	22	39.3	9	30	17	30.4	ALL: 0.66; 0.64	ALL: 0.12; 0.27
	AG	28	56	22	39.3	17	56.7	27	48.2	MDS: 0.2; 0.22	MDS: 0.91; 0.65
	GG	11	22	12	21.4	4	13.3	12	21.4	MM: 0.51; 0.39	MM: 0.24; 0.78
										NHL: 0.92; 0.71	NHL: 0.62; 0.73
	A	50	50	66	58.9	35	58.3	61	54.5
	G	50	50	46	41.1	25	41.7	51	45.5
rs4693084	GG	28	58.3	41	75.9	16	59.3	35	64.8	ALL: 0.25; 0.21	ALL: 0.36; 0.26
	GT	16	33.3	10	18.5	9	33.3	15	27.8	MDS: 0.12; 0.27	MDS: 0.16; 0.3
	TT	4	8.3	3	5.6	2	7.4	4	7.4	MM: 0.54; 0.41	MM: 0.6; 0.44
										NHL: 0.34; 0.65	NHL: 0.45; 0.69
	G	72	75	92	85.2	41	75.9	85	78.7
	T	24	25	16	14.8	13	24.1	23	21.3
rs4426765	AA	23	46.9	38	70.4	21	72.4	31	56.4	ALL: 0.034; 0.086	ALL: 0.008; 0.007
	AC	17	34.7	10	18.5	7	24.1	20	36.4	MDS: 0.009; 0.14	MDS: 0.034; 0.79
	CC	9	18.4	6	11.1	1	3.4	4	7.3	MM: 0.12; 0.054	MM: 0.51; 0.3
										NHL: 0.85; 0.71	NHL: 0.65; 0.43
	A	63	64.3	86	79.6	49	84.5	82	74.5
	C	35	35.7	22	20.4	9	15.5	28	25.5
rs28649799	AA	42	85.7	49	89.1	23	79.3	50	89.3	ALL: 0.27; 0.75	ALL: 0.41; 0.75
	AG	6	12.2	6	10.9	4	13.8	5	8.9	MDS: 0.43; 0.21	MDS: 0.26; 0.21
	GG	1	2	0	0	2	6.9	1	1.8	MM: 0.003; 0.26	MM: 0.09; 0.26
										NHL: 0.14; 0.32	NHL: 0.16; 0.32
	A	90	91.8	104	94.5	50	86.2	105	93.75
	G	8	8.2	6	5.5	8	13.8	7	6.25
rs4364254	TT	20	40	33	58.9	19	65.5	30	52.6	ALL: 0.89; 0.7	ALL: 0.084; 0.052
	TC	22	44	19	33.9	6	20.7	21	36.8	MDS: 0.049; 0.015	MDS: 0.53; 0.5
	CC	8	16	4	7.1	4	13.8	6	10.5	MM: 0.029; 0.071	MM: 0.056; 0.6
										NHL: 0.3; 0.15	NHL: 0.5; 0.77
	T	62	62	85	75.9	44	75.9	81	71.1
	C	38	38	27	24.1	14	24.1	33	28.9

Significant deviations (p < 0.05) are marked in bold. The first p-value represents a correlation between genotypes and the second p-value marks a correlation between alleles.